CTBP1

Chr 4AD

C-terminal binding protein 1

Also known as: BARS, HADDTS

This gene encodes a protein that binds to the C-terminus of adenovirus E1A proteins. This phosphoprotein is a transcriptional repressor and may play a role during cellular proliferation. This protein and the product of a second closely related gene, CTBP2, can dimerize. Both proteins can also interact with a polycomb group protein complex which participates in regulation of gene expression during development. Alternative splicing of transcripts from this gene results in multiple transcript variants. [provided by RefSeq, Jul 2008]

OMIMResearchGenerating clinical summary…
LOFmechanismADLOEUF 0.281 OMIM phenotype
Clinical SummaryCTBP1
Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 0.98). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
2 unique Pathogenic / Likely Pathogenic· 144 VUS of 371 total submissions
💊
Clinical Trials
1 active or recruiting trial — potential therapeutic options may be available

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint?
0.28LOEUF
pLI 0.984
Z-score 3.60
OE 0.06 (0.020.28)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
3.31Z-score
OE missense 0.45 (0.390.52)
126 obs / 282.5 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?
LoF OE?0.06 (0.020.28)
00.351.4
Missense OE?0.45 (0.390.52)
00.61.4
Synonymous OE?1.00
01.21.6
LoF obs/exp: 1 / 17.0Missense obs/exp: 126 / 282.5Syn Z: 0.02
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongCTBP1-related hypotonia, ataxia, developmental delay, and tooth enamel defect syndromeLOFAD

This gene — mechanism propensity

DN
0.4389th %ile
GOF
0.5465th %ile
LOF
0.71top 10%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to loss-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOFprediction above median · LOEUF 0.28
DN1 literature citation

Literature Evidence

DNDecreased complex I and IV activities in skeletal muscle of our patient suggests that BAX expression is altered by mutated CtBP1, with the c.991C>T p.(Arg331Trp) variant acting in a dominant-negative mechanism to disrupt mitochondrial function.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 28955726

ClinVar Variant Classifications

371 submitted variants in ClinVar

Classification Summary

Pathogenic1
Likely Pathogenic1
VUS144
Likely Benign188
Benign13
Conflicting8
1
Pathogenic
1
Likely Pathogenic
144
VUS
188
Likely Benign
13
Benign
8
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
1
0
0
1
Likely Pathogenic
0
1
0
0
1
VUS
7
122
12
3
144
Likely Benign
0
11
71
106
188
Benign
0
0
9
4
13
Conflicting
8
Total713592113355

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

148 pathogenic / likely-pathogenic (of 163) ClinVar copy-number / structural variants overlap CTBP1 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

CTBP1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.